Trial Profile
Clinical Trials Insight: 700043402
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 14 Apr 2009
Price :
$35
*
At a glance
- Drugs ACT 077825 (Primary) ; Enalapril
- Indications Cardiovascular disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Actelion Pharmaceuticals
- 14 Apr 2009 New trial record.
- 20 Mar 2009 Results presented at the 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, 2009.